Bacteria-targeted magnetic resonance contrast agents

Lauren M. Matosziuk (Inventor), Allison S. Harney (Inventor), Keith William Macrenaris (Inventor), Thomas J Meade (Inventor)

Research output: Patent

Abstract

The present invention relates to bacteria-targeted contrast agents for magnetic resonance imaging (MRI). In particular, the present invention relates to bacteria targeted MRI contrast agents that can be used to detect bacteria in vivo or in vitro. In certain embodiments, the contrast agents comprise a metal chelate conjugated to at least two Zn-dipicolylamine groups.
Original languageEnglish (US)
Patent number9566355
Filing date3/6/14
StatePublished - Feb 14 2017

Fingerprint Dive into the research topics of 'Bacteria-targeted magnetic resonance contrast agents'. Together they form a unique fingerprint.

Cite this